Abstract
Information may be provided to a broader range of consumers. No longer will results of studies be limited to regulators and scientific/medical cognoscenti. With greater access to posted documents on a variety of portals, the public will seek and access information that is important for informed decision-making. The patient will have a stronger voice in determining their treatment, and this will extend to end-of-life decisions. Social media will amplify results and will spread misinterpretations and poor-quality data. Caveat emptor! Contributors include: Samuel Entwisle, PhD, Medical Writer, Center for Information and Study on Clinical Research Participation (CISCRP), Boston, MA Zack Fey, BS, Medical Writer, Center for Information and Study on Clinical Research Participation (CISCRP), Boston, MA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
